Renaissance Technologies - DELMAR PHARMACEUTICALS INC ownership

DELMAR PHARMACEUTICALS INC's ticker is DMPI and the CUSIP is 247078306. A total of 12 filers reported holding DELMAR PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of DELMAR PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$63,000
+1160.0%
91,110
+663.1%
0.00%
Q1 2020$5,000
-58.3%
11,940
-31.8%
0.00%
Q4 2019$12,00017,5000.00%
Other shareholders
DELMAR PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Virtu Financial LLC 68,359$47,0000.01%
BREWIN DOLPHIN LTD 30,000$20,6340.00%
Renaissance Technologies 91,110$63,0000.00%
BARCLAYS PLC 36,500$25,0000.00%
UBS Group AG 8,045$6,0000.00%
OSAIC HOLDINGS, INC. 4,000$3,0000.00%
NORTHERN TRUST CORP 12,441$9,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MORGAN STANLEY 250$00.00%
BANK OF MONTREAL /CAN/ 427$00.00%
View complete list of DELMAR PHARMACEUTICALS INC shareholders